EyePod

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of August 27, 2023. 

In this episode, Ophthalmology Times ' co-chief medical editors Peter J. McDonnell, MD, and Neda Shamie, MD, delve into the clinical nuances of Demodex blepharitis. Through personal anecdotes, they stress its underrecognized gravity and discuss diagnostic cues like collarettes. The experts share their enthusiasm for improved treatments, echoing the transformative impact seen in dry eye care.

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of August 20, 2023. 

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of August 13, 2023. 

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of August 6, 2023. 

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of July 30, 2023. 

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of July 16, 2023. 

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of July 9, 2023. 

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  Take a look at a review of the highlights from Ophthalmology Times during the week of July 2, 2023. 

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  In the sport, which is a hybrid of badminton, ping-pong and tennis, players use a plastic-perforated ball, slightly heavier than a whiffle ball, and wooden or composite paddles that are about twice the size of ping-pong paddles, with a high potential for eye injuries.  

Editor's Note: This podcast was generated from Ophthalmology Times content using an AI platform.  A new study found an approach that identifies high-risk patients so all preemies don’t need to undergo an invasive eye exam. 

William B. Trattler, MD, highlights some of the novel therapies for dry eye that have recently been approved by the FDA, along with various treatment approaches that are in development. 

David Hutton from Ophthalmology Times and Jay Duker talk about wet AMD and the burdens of treatment on patients thanks to the consistent need for follow-ups and more. 

Eyenuk Inc. founder and CEO Kaushal Solanki, PhD, went from working for the Defense Department to founding a company with a focus on artificial intelligence for ophthalmology. Find out what led him to make that jump.

Ehsan Sadri, MD, FACS, and William Trattler, MD, highlight some of the pending FDA approvals and PDUFA dates in the anterior segment sector and what these products will mean for ophthalmologists and their patients.

Dr. Jai Parekh, a clinical associate professor of Ophthalmology/The New York Eye & Infirmary of the Mount Sinai School of Medicine and David Hutton, Managing Editor of Ophthalmology Times discuss the importance of ocular health prior to cataract and refractive surgery, specifically with osmolarity testing.

On this part two episode with Colin Carr, founder and CEO of CARR, we hear more about commercial real estate dos and don'ts when managing the space of your practice. Tune in now for the discussion with  Ophthalmology Times®  executive editor, David Hutton.

Colin Carr, founder and CEO of CARR, chats with Ophthalmology Times' David Hutton in this part one episode of the EyePod. Colin hits on some hot real estate topics in the healthcare industry, including top mistakes healthcare providers make with their office space, how to decide whether you're going to purchase or lease, and how healthcare providers can save $100k or more on their next lease renew...

In this episode of EyePod, Ora Clinical’s Keith Lane discusses uveitis and flare ups, as well as challenges in clinical trials.

Keith Lane of Orange Clinical joins us to discuss the current state of gene therapy and its standardized endpoints, and the challenges gene therapy has faced, particularly in relation to ophthalmology.

Retinopathy of prematurity expert C. Armitage Harper, III, MD, of the Austin Retina Associates in Austin, Texas, discusses his experience in treating ROP cases across the globe, and his mission prevent pre-term blindness in infants. 

George O. Waring IV, MD, FACS, discusses the latest results from the GEMINI 1 clinical trial (by Allergan, an Abbvie company) of AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia.

Michael Rivers, MD, director of Ophthalmology at Modernizing Medicine, discusses Aetna's new policy requiring prior authorization for cataract surgery, its impact on ophthalmologists and patients, as well as potential solutions — and additional issues — that may arise in the future as a result. 

Elizabeth Yeu, MD, a cornea cataract and refractive surgeon at Virginia Eye Consultants shares results from the Saturn 1 pivotal phase 2b3 trial evaluating the safety and efficacy of a new investigational therapeutic from Tarsus Pharmaceuticals called TP03 (lotilaner ophthalmic solution 0.25%), for the treatment of patients diagnosed with Demodex blepharitis.

Uday Devgan, MD, FACS, of Devgan Eye Surgery in Los Angeles and Beverly Hills, CA, answers a few key questions his patients have asked when considering cataract surgery.